Wilfried M.
- Country
- Belgium
- Department
- N/A
Research Overview
- Evaluation of Acetazolamide and SGLT2 Inhibitors in Managing Volume Overload in Acute Heart Failure Patients
- HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation
- A prospective, randomized, controlled clinical pilot trial investigating the partial down-titration of guideline-directed medical therapy in patients with heart failure in remission
Data & Insights
Has run more than one trial at 1 of 297 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating patients with acute heart failure, focusing particularly on innovative therapeutic approaches for managing volume overload conditions.
- Heart Failure Management
- Volume Status Optimization
- Diuretic Therapy
Primary research interest centers on investigating combination therapies to enhance natriuresis in heart failure patients.
Therapeutic Innovation
The investigator explores novel therapeutic combinations, including SGLT2 inhibitors and carbonic anhydrase inhibitors, for cardiovascular conditions.
- Combination Drug Therapy
- Fluid Management Strategies
- Treatment Optimization
Research focuses on developing enhanced treatment protocols for acute cardiac conditions.
Clinical Management
Expertise in treating complex cardiovascular disorders with particular emphasis on fluid balance and hemodynamic stabilization.
- Acute Cardiac Care
- Fluid Balance Management
- Emergency Cardiovascular Medicine
Specializes in developing treatment strategies for acute cardiac emergencies requiring immediate intervention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.